OtherSPECIAL CONTRIBUTION
Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting
David M. Goldenberg, Edmund A. Rossi, Robert M. Sharkey, William J. McBride and Chien-Hsing Chang
Journal of Nuclear Medicine January 2008, 49 (1) 158-163; DOI: https://doi.org/10.2967/jnumed.107.046185
David M. Goldenberg
Edmund A. Rossi
Robert M. Sharkey
William J. McBride
In this issue
Journal of Nuclear Medicine
Vol. 49, Issue 1
January 2008
Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting
David M. Goldenberg, Edmund A. Rossi, Robert M. Sharkey, William J. McBride, Chien-Hsing Chang
Journal of Nuclear Medicine Jan 2008, 49 (1) 158-163; DOI: 10.2967/jnumed.107.046185
Jump to section
Related Articles
Cited By...
- Pretargeting: A Path Forward for Radioimmunotherapy
- A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
- {alpha}- Versus {beta}-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts
- Development of a Radiolabeled Irreversible Peptide Ligand for PET Imaging of Vascular Endothelial Growth Factor
- Advances in the treatment of hematologic malignancies using immunoconjugates
- Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
- Pretargeted 177Lu Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colonic Tumors in Mice
- Pretargeted Immuno-Positron Emission Tomography Imaging of Carcinoembryonic Antigen-Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
- CD20-targeted tetrameric interferon-{alpha}, a novel and potent immunocytokine for the therapy of B-cell lymphomas
- Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia
- A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma